Your browser doesn't support javascript.
loading
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
Bueno-Muiño, Coralia; Echavarría, Isabel; López-Tarruella, Sara; Roche-Molina, Marta; Del Monte-Millán, María; Massarrah, Tatiana; Jerez, Yolanda; Ayala de la Peña, Francisco; García-Sáenz, José Ángel; Moreno, Fernando; Rodríguez-Lescure, Álvaro; Malón-Giménez, Diego; Ballesteros García, Ana Isabel; Marín-Aguilera, Mercedes; Galván, Patricia; Brasó-Maristany, Fara; Waks, Adrienne G; Tolaney, Sara M; Mittendorf, Elizabeth A; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S; Perou, Charles M; Paré, Laia; Villacampa, Guillermo; Prat, Aleix; Martín, Miguel.
Affiliation
  • Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, Madrid, Spain.
  • Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
  • López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Geicam, Universidad Complutense, Madrid, Spain.
  • Roche-Molina M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Del Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
  • Massarrah T; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
  • Jerez Y; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
  • Ayala de la Peña F; Hematology and Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain.
  • García-Sáenz JÁ; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, CIBERONC, Madrid, Spain.
  • Moreno F; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos, CIBERONC, Madrid, Spain.
  • Rodríguez-Lescure Á; Medical Oncology Department, General Universitario de Elche, Alicante, Spain.
  • Malón-Giménez D; Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Ballesteros García AI; Department of Medical Oncology, Hospital Universitario de La Princesa, Madrid, Spain.
  • Marín-Aguilera M; Reveal Genomics, Barcelona, Spain.
  • Galván P; Translational Genomics and Targeted Therapies in Solid Tumors, Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tolaney SM; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
  • Mittendorf EA; Harvard Medical School, Boston, Massachusetts.
  • Vivancos A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Villagrasa P; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
  • Parker JS; Harvard Medical School, Boston, Massachusetts.
  • Perou CM; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
  • Paré L; Harvard Medical School, Boston, Massachusetts.
  • Villacampa G; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Prat A; Cancer Genomics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Martín M; Reveal Genomics, Barcelona, Spain.
JAMA Oncol ; 9(6): 841-846, 2023 06 01.
Article in En | MEDLINE | ID: mdl-37103916
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: